Last reviewed · How we verify
Venous puncture in elderly patients
Venous puncture in elderly patients involves the use of a needle to collect blood from a vein, often for diagnostic or therapeutic purposes.
Venous puncture in elderly patients involves the use of a needle to collect blood from a vein, often for diagnostic or therapeutic purposes. Used for Venous puncture in elderly patients.
At a glance
| Generic name | Venous puncture in elderly patients |
|---|---|
| Sponsor | Centre Hospitalier Universitaire, Amiens |
| Modality | Biologic |
| Phase | Phase 3 |
Mechanism of action
This procedure typically requires the use of a tourniquet to constrict the vein, followed by the insertion of a needle into the vein to collect a blood sample. The blood is then analyzed for various parameters, such as glucose levels, electrolyte balance, or blood cell counts.
Approved indications
- Venous puncture in elderly patients
Common side effects
- Hematoma
- Bruising
- Nerve damage
Key clinical trials
- Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis
- Weekly Monitoring Strategy of Capillary INR Versus Monthly Monitoring Strategy of Venous INR in Elderly Patients in a Nursing Home. (NA)
- Wellbeing and Survival Improvement With Event Reduction by Ablation for Atrial Fibrillation in the Very Elderly (NA)
- Age-related Conditions in the Context of Multimorbidity and Frailty: Relative Weight of Frailty in Determining the Course and Outcomes of Different Chronic Diseases and Viceversa
- Plasma Biomarkers of Muscle Metabolism During Exercise to the Assessment of Insulin Resistance in CKD Dialysis Patients (NA)
- Development of an Artificial Intelligence Model for the Identification and Prevention of Smoking-related Diseases. (NA)
- Antibiotic Dosing in Geriatric Patients At the Emergency Department
- Spatial and Ocular Trajectories for the Early Diagnosis of Alzheimer's Disease. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: